<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04857385</url>
  </required_header>
  <id_info>
    <org_study_id>RAPHE-001</org_study_id>
    <nct_id>NCT04857385</nct_id>
  </id_info>
  <brief_title>Radial Artery Puncture Hemostasis Study</brief_title>
  <acronym>RAPHE</acronym>
  <official_title>Radial Artery Puncture Hemostasis: Physical, Biological and Chemical Methods</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Semmelweis University Heart and Vascular Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Semmelweis University Heart and Vascular Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      RAPHE is an open label randomized clinical trial to assess physical, biological and chemical&#xD;
      methods of radial artery puncture hemostasis following coronary catheterization.&#xD;
&#xD;
      A total of 600 subjects will be randomized in a 1:1:1 fashion to either the StatSeal,&#xD;
      Axiostat or TR Band hemostasis devices.&#xD;
&#xD;
      Follow-up of the subject will take place 60 days after the index procedure.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 14, 2021</start_date>
  <completion_date type="Anticipated">January 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Radial artery occlusion</measure>
    <time_frame>24 hours post-procedure or at hospital discharge (whichever comes first)</time_frame>
    <description>Frequency of radial artery occlusion after hemostasis</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Radial artery occlusion</measure>
    <time_frame>60 days (+/-10 days) post-procedure</time_frame>
    <description>Frequency of radial artery occlusion after hemostasis</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Radial artery (pseudo)aneurysm formation</measure>
    <time_frame>24 hours post-procedure or at hospital discharge (whichever comes first)</time_frame>
    <description>Frequency of radial artery (pseudo)aneurysm formation after hemostasis</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Radial artery (pseudo)aneurysm formation</measure>
    <time_frame>60 days (+/-10 days) post-procedure</time_frame>
    <description>Frequency of radial artery (pseudo)aneurysm formation after hemostasis</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Radial artery fistula formation</measure>
    <time_frame>24 hours post-procedure or at hospital discharge (whichever comes first)</time_frame>
    <description>Frequency of radial artery arteriovenous fistula formation after hemostasis</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Radial artery fistula formation</measure>
    <time_frame>60 days (+/-10 days) post-procedure</time_frame>
    <description>Frequency of radial artery arteriovenous fistula formation after hemostasis</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Radial artery bleeding</measure>
    <time_frame>24 hours post-procedure or at hospital discharge (whichever comes first)</time_frame>
    <description>Bleeding from the radial artery puncture, classified via the EASY method</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Radial artery bleeding</measure>
    <time_frame>60 days (+/-10 days) post-procedure</time_frame>
    <description>Bleeding from the radial artery puncture, classified via the EASY method</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Initial compression time of hemostatsis device</measure>
    <time_frame>Up to 30 minutes post-procedure</time_frame>
    <description>Initial time (in minutes) of the hemostasis device, needed to achieve primary patent hemostasis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HouOverall compression time</measure>
    <time_frame>Up to 24 hours post-procedure</time_frame>
    <description>Overall time (in minutes) of device use as a hemostatis tool</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">600</enrollment>
  <condition>Radial Artery Hemostasis</condition>
  <arm_group>
    <arm_group_label>Terumo TR Band</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Physical standard of care radial hemostasis device.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>StatSeal</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Potassium-ferrate based chemical hemostasis device.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Axiostat</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Chitosan based biological hemostasis device.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Radial artery hemostasis</intervention_name>
    <description>Each of the devices will be assessed for radial artery hemostasis.</description>
    <arm_group_label>Axiostat</arm_group_label>
    <arm_group_label>StatSeal</arm_group_label>
    <arm_group_label>Terumo TR Band</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Coronary angiogram planned from a radial artery approach&#xD;
&#xD;
          -  Use of 5, 6 or 7 French sheaths&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Radial artery diameter &lt;1.8 mm as measured via ultrasound&#xD;
&#xD;
          -  Established peripheral arterial disease&#xD;
&#xD;
          -  Known autoimmune illness&#xD;
&#xD;
          -  Hemodynamic instability&#xD;
&#xD;
          -  Pregnant or nursing&#xD;
&#xD;
          -  Condition following resuscitation&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>István F Édes, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Semmelweis Univeristy Heart and Vascular Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>István F Édes, MD PhD</last_name>
    <phone>+36-1-458-6810</phone>
    <email>edes789@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Zoltán Ruzsa, MD PhD</last_name>
    <phone>+36-62-545-801</phone>
    <email>zruzsa25@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Szeged, Department of Invasive Cardiology</name>
      <address>
        <city>Szeged</city>
        <state>Csongád-Csanád</state>
        <zip>6725</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zoltán Ruzsa, MD PhD</last_name>
      <phone>+36-62-545-801</phone>
      <email>zruzsa25@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Department of Cardiology and Cardiac Surgery</name>
      <address>
        <city>Debrecen</city>
        <state>Hajdú-Bihar</state>
        <zip>4032</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tibor Szűk, MD PhD</last_name>
      <phone>+36 52 411 600</phone>
      <email>tszuk01@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Semmelweis University Heart and Vascular Center</name>
      <address>
        <city>Budapest</city>
        <zip>1122</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>István F Édes, MD PhD</last_name>
      <phone>+36-1-458-6810</phone>
      <email>edes789@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Hungary</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>April 20, 2021</study_first_submitted>
  <study_first_submitted_qc>April 20, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 23, 2021</study_first_posted>
  <last_update_submitted>November 12, 2021</last_update_submitted>
  <last_update_submitted_qc>November 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Semmelweis University Heart and Vascular Center</investigator_affiliation>
    <investigator_full_name>Istvan Edes</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Radial artery puncture</keyword>
  <keyword>Radial artery occlusion</keyword>
  <keyword>Radial artery bleeding</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemostatics</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

